http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Shim So Hyun,Lee Su Young,Jung Inkyung,Heo Seok-Jae,Han You Jung,Kwak Dong Wook,Kim Min Hyoung,Park Hee Jin,Chung Jin Hoon,Lim Ji Hyae,Kim Moon Young,Cha Dong Hyun,Shim Sung Shin,Cho Hee Young,Ryu Hyu 대한의학회 2024 Journal of Korean medical science Vol.39 No.3
Background: Postpartum depression (PPD) can negatively affect infant well-being and child development. Although the frequency and risk factors of PPD symptoms might vary depending on the country and culture, there is limited research on these risk factors among Korean women. This study aimed to elucidate the potential risk factors of PPD throughout pregnancy to help improve PPD screening and prevention in Korean women. Methods: The pregnant women at 12 gestational weeks (GW) were enrolled from two obstetric specialized hospitals from March 2013 to November 2017. A questionnaire survey was administered at 12 GW, 24 GW, 36 GW, and 4 weeks postpartum. Depressive symptoms were assessed using the Edinburgh Postnatal Depression Scale, and PPD was defined as a score of ≥ 10. Results: PPD was prevalent in 16.3% (410/2,512) of the participants. Depressive feeling at 12 GW and postpartum factors of stress, relationship with children, depressive feeling, fear, sadness, and neonatal intensive care unit admission of baby were significantly associated with a higher risk of PPD. Meanwhile, high postpartum quality of life and marital satisfaction at postpartum period were significantly associated with a lower risk of PPD. We developed a model for predicting PPD using factors as mentioned above and it had an area under the curve of 0.871. Conclusion: Depressive feeling at 12 GW and postpartum stress, fear, sadness, relationship with children, low quality of life, and low marital satisfaction increased the risk of PPD. A risk model that comprises significant factors can effectively predict PPD and can be helpful for its prevention and appropriate treatment.
Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma
Park, Junseong,Kim, Chang Gon,Shim, Jin-Kyoung,Kim, Jong Hoon,Lee, Hoyoung,Lee, Jae Eun,Kim, Min Hwan,Haam, Keeok,Jung, Inkyung,Park, Su-Hyung,Chang, Jong Hee,Shin, Eui-Cheol,Kang, Seok-Gu Informa UK (TaylorFrancis) 2019 Oncoimmunology Vol.8 No.1